The influence of zofenopril in combination with spironolactone on the morpho-functional state of the myocardium in patients after a myocardial infarction in the presence of obesity

Abstract

Acute myocardial infarction (AMI) remains the leading cause of death from cardiovascular disease in the world. One of the risk factors for developing coronary heart disease (CHD) associated with the risk of AMI is obesity. Aim – to study the effectiveness of treatment with ACE-inhibitors (zofenopril vise versa enalapril) in combination with spironolacton after a myocardial infarction in patients with low ejection fraction and obesity of the abdominal type on the parameters of the morphofunctionalstate of the myocardium.